Vincent Carlier

612 total citations
21 papers, 476 citations indexed

About

Vincent Carlier is a scholar working on Immunology, Molecular Biology and Surgery. According to data from OpenAlex, Vincent Carlier has authored 21 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Vincent Carlier's work include Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (5 papers) and Immunotherapy and Immune Responses (4 papers). Vincent Carlier is often cited by papers focused on Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (5 papers) and Immunotherapy and Immune Responses (4 papers). Vincent Carlier collaborates with scholars based in Belgium, France and Germany. Vincent Carlier's co-authors include Marc Jacquemin, Luc VanderElst, Wim Janssens, Jean-Marie Saint-Remy, Jean‐Marie Saint‐Remy, Bo Wu, Bart De Geest, Frank Jacobs, Eline Van Craeyveld and E.A. Stura and has published in prestigious journals such as Blood, The Journal of Immunology and Journal of the American College of Cardiology.

In The Last Decade

Vincent Carlier

20 papers receiving 470 citations

Peers

Vincent Carlier

IMMUN

SURGE

PHYSI

Ramakrishna Edukulla United States

Catherine L. Keech Australia

Ko Okumura Japan

Lakeisha Esau United States

Nahir Garabatos Spain

Thuy Le United States

Rita Vasconcellos Brazil

Tara M. Engeman United States

R G Oldroyd United Kingdom

Toshiyuki Ikemoto Japan

Ramakrishna Edukulla United States

Vincent Carlier

148 ×0.7

IMMUN

260 ×2.9

163 ×1.9

SURGE

70 ×1.0

PHYSI

56 ×0.8

Citations per year, relative to Vincent Carlier Vincent Carlier (= 1×) peers Ramakrishna Edukulla

Countries citing papers authored by Vincent Carlier

Since Specialization

Citations

This map shows the geographic impact of Vincent Carlier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Carlier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Carlier more than expected).

Fields of papers citing papers by Vincent Carlier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Carlier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Carlier. The network helps show where Vincent Carlier may publish in the future.

Co-authorship network of co-authors of Vincent Carlier

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Carlier. A scholar is included among the top collaborators of Vincent Carlier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Carlier. Vincent Carlier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rampelbergh, Jean Van, Peter Achenbach, Richard David Leslie, et al.. (2024). First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes: an exploratory analysis of immune biomarkers. BMC Medicine. 22(1). 259–259. 10 indexed citations

Rampelbergh, Jean Van, Peter Achenbach, Richard David Leslie, et al.. (2023). First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes. BMC Medicine. 21(1). 190–190. 13 indexed citations

Carlier, Vincent, et al.. (2022). DMXTM Demonstrator for CO2 Capture: First Results of Experimental Campaign. 1 indexed citations

Broutin, Paul, et al.. (2018). Pilot Plant in Dunkirk for Demonstrating the DMX TM Process. SSRN Electronic Journal. 3 indexed citations

Carlier, Vincent, et al.. (2016). Thioreductase-Containing Epitopes Inhibit the Development of Type 1 Diabetes in the NOD Mouse Model. Frontiers in Immunology. 7. 67–67. 13 indexed citations

Carlier, Vincent, et al.. (2015). MHC Class II-Restricted Epitopes Containing an Oxidoreductase Activity Prompt CD4+ T Cells with Apoptosis-Inducing Properties. Frontiers in Immunology. 6. 449–449. 6 indexed citations

Carlier, Vincent, et al.. (2015). Suppression of Immune Response to Adenovirus Serotype 5 Vector by Immunization with Peptides Containing an MHC Class II Epitope and a Thio-Oxidoreductase Motif. Human Gene Therapy. 27(3). 230–243. 3 indexed citations

Vooght, Vanessa De, Vincent Carlier, Fien Devos, et al.. (2013). B-lymphocytes as Key Players in Chemical-Induced Asthma. PLoS ONE. 8(12). e83228–e83228. 21 indexed citations

Singh, Neha, Eline Van Craeyveld, Marc Tjwa, et al.. (2012). Circulating Apoptotic Endothelial Cells and Apoptotic Endothelial Microparticles Independently Predict the Presence of Cardiac Allograft Vasculopathy. Journal of the American College of Cardiology. 60(4). 324–331. 39 indexed citations

10.

Rinaldi, Manuela, An Lehouck, Renaud Lavend’homme, et al.. (2012). Antielastin B-cell and T-cell immunity in patients with chronic obstructive pulmonary disease. Thorax. 67(8). 694–700. 35 indexed citations

11.

Carlier, Vincent, Luc VanderElst, Wim Janssens, Marc Jacquemin, & Jean-Marie Saint-Remy. (2012). Increased Synapse Formation Obtained by T Cell Epitopes Containing a CxxC Motif in Flanking Residues Convert CD4+ T Cells into Cytolytic Effectors. PLoS ONE. 7(10). e45366–e45366. 8 indexed citations

12.

Janssens, Wim, Vincent Carlier, Luc VanderElst, et al.. (2010). Retroviral Vectors Induce Epigenetic Chromatin Modifications and IL-10 Production in Transduced B Cells via Activation of Toll-like Receptor 2. Molecular Therapy. 19(4). 711–722. 14 indexed citations

13.

Feng, Yingmei, Stephanie Gordts, Feng Chen, et al.. (2010). Topical HDL administration reduces vein graft atherosclerosis in apo E deficient mice. Atherosclerosis. 214(2). 271–278. 24 indexed citations

14.

Janssens, Wim, Luc VanderElst, Vincent Carlier, et al.. (2009). In Vivo Induction of Type 1-Like Regulatory T Cells Using Genetically Modified B Cells Confers Long-Term IL-10-Dependent Antigen-Specific Unresponsiveness. The Journal of Immunology. 183(12). 8232–8243. 34 indexed citations

15.

Feng, Yingmei, Miranda Van Eck, Eline Van Craeyveld, et al.. (2008). Critical role of scavenger receptor-BI–expressing bone marrow–derived endothelial progenitor cells in the attenuation of allograft vasculopathy after human apo A-I transfer. Blood. 113(3). 755–764. 56 indexed citations

16.

Carlier, Vincent, et al.. (2007). Induction and efficacy of cytolytic regulatory T cells in experimental asthma. 244–246. 1 indexed citations

17.

Stura, E.A., et al.. (2006). Three-dimensional structure and IgE-binding properties of mature fully active Der p 1, a clinically relevant major allergen. Journal of Allergy and Clinical Immunology. 117(3). 571–576. 61 indexed citations

18.

Carlier, Vincent, Luc VanderElst, Marc Jacquemin, & Jean-Marie Saint-Remy. (2006). Regulatory CD4⁺T cells in allergic asthma. Expert Review of Clinical Immunology. 2(5). 737–744. 1 indexed citations

19.

Janssens, Wim, Vincent Carlier, Bo Wu, et al.. (2003). CD4+CD25+ T Cells Lyse Antigen-Presenting B Cells by Fas-Fas Ligand Interaction in an Epitope-Specific Manner. The Journal of Immunology. 171(9). 4604–4612. 113 indexed citations

20.

Wu, Bo, et al.. (2002). The Dermatophagoides pteronyssinus Group 2 Allergen Contains a Universally Immunogenic T Cell Epitope. The Journal of Immunology. 169(5). 2430–2435. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact